Fjarde Ap-fonden’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-79,584
| Closed | -$9.21M | – | 561 |
|
|
2023
Q3 | $9.21M | Sell |
79,584
-3,800
| -5% | -$440K | 0.12% | 174 |
|
|
2023
Q2 | $8.58M | Buy |
83,384
+1,700
| +2% | +$175K | 0.11% | 206 |
|
|
2023
Q1 | $8.91M | Sell |
81,684
-9,200
| -10% | -$1M | 0.12% | 189 |
|
|
2022
Q4 | $10.3M | Sell |
90,884
-1,600
| -2% | -$182K | 0.15% | 159 |
|
|
2022
Q3 | $7.38M | Hold |
92,484
| – | – | 0.09% | 220 |
|
|
2022
Q2 | $7.38M | Buy |
92,484
+16,200
| +21% | +$1.29M | 0.09% | 220 |
|
|
2022
Q1 | $8.03M | Buy |
76,284
+4,384
| +6% | +$461K | 0.08% | 265 |
|
|
2021
Q4 | $7.75M | Buy |
71,900
+600
| +0.8% | +$64.7K | 0.07% | 294 |
|
|
2021
Q3 | $7.81M | Sell |
71,300
-2,700
| -4% | -$296K | 0.07% | 277 |
|
|
2021
Q2 | $6.93M | Sell |
74,000
-4,400
| -6% | -$412K | 0.06% | 320 |
|
|
2021
Q1 | $7.22M | Sell |
78,400
-700
| -0.9% | -$64.4K | 0.07% | 298 |
|
|
2020
Q4 | $5.79M | Buy |
+79,100
| New | +$5.79M | 0.05% | 334 |
|